BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7878934)

  • 1. Induction of T-cell anergy by OKT3 requires cyclosporine-insensitive activation signals.
    Willems F; Andris F; Abramowicz D; Piérard G; Wissing M; Leo O; Goldman M
    Transplant Proc; 1995 Feb; 27(1):1425-7. PubMed ID: 7878934
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-mediated induction of anergy in the Jurkat T-cell line.
    Gallichio MH; Conti DJ; Lempert N; Gruber SA; Geiselhart L; Freed BM
    Transplant Proc; 1994 Dec; 26(6):3458-9. PubMed ID: 7998221
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effects of gangliosides and cyclosporine on lymphocyte activation: analysis of cytokine gene mRNA transcripts.
    Ausiello CM; Adorno D; Graña G; Urbani F; Spagnoli GC; Sconocchia G; Cococcetta N; Casciani CU
    Transplant Proc; 1993 Jun; 25(3):2315-6. PubMed ID: 8516913
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell.
    Yamamoto T; Hattori M; Yoshida T
    Immunology; 2007 Jul; 121(3):383-91. PubMed ID: 17376194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 4 beta 1 (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation.
    Udagawa T; Woodside DG; McIntyre BW
    J Immunol; 1996 Sep; 157(5):1965-72. PubMed ID: 8757316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
    Bonnefoy-Berard N; Revillard JP
    J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 10. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis.
    Yamasaki H; Ando M; Brazer W; Center DM; Cruikshank WW
    J Immunol; 1999 Sep; 163(6):3516-23. PubMed ID: 10477626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
    De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
    Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine and Sirolimus on interleukin-15-driven proliferation of OKT3-preactivated human lymphocytes.
    Degiannis D; Kalteziotis V; Thalassinos A; Kapsalis A; Kroupis C; Koniavitou K
    Transplant Proc; 1998 Jun; 30(4):948-9. PubMed ID: 9636382
    [No Abstract]   [Full Text] [Related]  

  • 13. OKT3-associated adverse reactions: mechanistic basis and therapeutic options.
    Suthanthiran M; Fotino M; Riggio RR; Cheigh JS; Stenzel KH
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):39-44. PubMed ID: 2530898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
    Laxminarayana D; Kammer GM
    J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro.
    Matsuura T; Negita M; Ikegami M; Imanishi M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Akiyama T
    Transplant Proc; 1992 Feb; 24(1):410-2. PubMed ID: 1371623
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
    Izeradjene K; Quemeneur L; Michallet MC; Bonnefoy-Berard N; Revillard JP
    Transplant Proc; 2001 May; 33(3):2110-1. PubMed ID: 11377468
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells.
    Staruch MJ; Camacho R; Dumont FJ
    Cell Immunol; 1998 Dec; 190(2):121-31. PubMed ID: 9878113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.
    Le Gall F; Reusch U; Moldenhauer G; Little M; Kipriyanov SM
    J Immunol Methods; 2004 Feb; 285(1):111-27. PubMed ID: 14871540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T cell anergy by low numbers of agonist ligands.
    Korb LC; Mirshahidi S; Ramyar K; Sadighi Akha AA; Sadegh-Nasseri S
    J Immunol; 1999 Jun; 162(11):6401-9. PubMed ID: 10352253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.